Enamel Matrix Derivative and Xenograft for Mandibular Molar Furcation Defects
NCT07776756 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2026-08-20
Summary
This randomized controlled clinical trial aims to compare two regenerative surgical approaches for the treatment of mandibular molar Class II furcation defects in patients with periodontitis. Eligible furcation defects will be randomly assigned to receive either xenograft bone combined with enamel matrix derivative (EMD) or xenograft bone combined with a collagen membrane. Both approaches are used to support periodontal tissue regeneration.
Participants will be followed for approximately 7 months. The study will evaluate postoperative pain and patient-reported satisfaction, periodontal clinical parameters, changes in furcation defect volume and relative bone density on cone-beam computed tomography (CBCT), and changes in gingival crevicular fluid TWEAK levels. Clinical and radiographic outcomes will be assessed before surgery and during follow-up, including at 3 and 6 months after surgery.
The study is intended to determine whether xenograft bone combined with EMD provides clinical, radiographic, biological, and patient-reported outcomes comparable or superior to xenograft bone combined with a collagen membrane in the regenerative treatment of mandibular molar Class II furcation defects.
Conditions
- Class II Furcation Defect
Interventions
- PROCEDURE
-
Periodontal Regenerative Surgery With Xenograft and Enamel Matrix Derivative
Periodontal regenerative surgery is performed using xenograft bone combined with enamel matrix derivative (EMD). After flap elevation, thorough defect debridement, and root surface conditioning with 24% EDTA for 2 minutes, EMD is applied to the root surface associated with the furcation defect. The xenograft bone is mixed with EMD and placed to completely fill the defect. The flap is then repositioned and sutured.
- PROCEDURE
-
Periodontal Regenerative Surgery With Xenograft and Collagen Membrane
Periodontal regenerative surgery is performed using xenograft bone combined with a resorbable collagen membrane. After flap elevation, thorough defect debridement, and root surface conditioning with 24% EDTA for 2 minutes, the xenograft bone is mixed with sterile saline and placed to completely fill the furcation defect. A trimmed resorbable collagen membrane is positioned to completely cover the defect and secured before flap repositioning and suturing.
Sponsors & Collaborators
-
University of Medicine and Pharmacy at Ho Chi Minh City
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-29
- Primary Completion
- 2027-09-29
- Completion
- 2027-09-30
Countries
- Vietnam
Study Locations
More Related Trials
-
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
NCT02218515 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Periodontal Intrabony Defects With Liquid Platelet-Rich Fibrin Mixed With Denaturated Albumin Gel (ALB_PRF)
NCT06798116 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Regenerative Combined Therapy With Enamel Matrix Derivative and Biphasic Calcium Phosphate Graft
NCT02828423 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Periodontal Intra-bony Defects With a Volume Stable Collagen Matrix or Deproteinized Bovine Bone Mineral With 10% Collagen
NCT06676826 ·Status: RECRUITING ·Phase: NA
-
Regenerative Potential of a Collagen Membrane Associated or Not to Bovine Bone in Class II Furcation Defects.
NCT04450849 ·Status: COMPLETED ·Phase: PHASE4
-
Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage
NCT02456337 ·Status: COMPLETED ·Phase: PHASE4
-
Flapless Application of Enamel Matrix Derivative in Class II Mandibular Furcation Defects
NCT05541614 ·Status: UNKNOWN ·Phase: NA
-
Clinical and Radiographic Assessment of Efficacy of Modified Minimally Invasive SurgicalTechnique (M-MIST) Alone and Combined With Enamel Matrix Proteins and Ox-derived Bone Graft in the Treatment of Single Bone Defects Between Teeth.
NCT07310732 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of Connective Tissue Graft and Enamel Matrix Derivative in the Treatment of Intrabony Periodontal Defects
NCT07233733 ·Status: COMPLETED ·Phase: NA
-
Mandibular Furcation II Regeneration
NCT04059445 ·Status: TERMINATED ·Phase: PHASE4
-
EMD for Treatment of Proximal Class-II Furcation Involvements
NCT03320135 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Two Types of Matrix (Mucograft® and Mucoderm®) Associated With Coronally Advanced Flap
NCT03667105 ·Status: COMPLETED ·Phase: NA
-
Perforated Collagen Membrane With Nanohydroxyapatite for Intrabony Defects
NCT03399279 ·Status: COMPLETED ·Phase: NA
-
Recombinant Human Platelet-derived Growth Factor in Combination With Collagen Matrix
NCT04462237 ·Status: COMPLETED ·Phase: NA
-
Regeneration of Human Intrabony Defects With rhFGF-2/HA
NCT02337166 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Periodontal Intrabony Defects With A-PRF+ or EMD
NCT04404374 ·Status: COMPLETED ·Phase: NA
-
Advanced Platelet-Rich Fibrin and Coronally Advanced Flap for Gingival Recession Treatment
NCT07624591 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Volume Stable Collagen Matrix in the Regenerative Outcome of Periodontal Intrabony Defects
NCT05569473 ·Status: COMPLETED ·Phase: NA
-
Concentrated Growth Factors in Regenerative Therapy in Furcation Involvements in Humans
NCT03180658 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts
NCT07146776 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Enamel Matrix Derivative as an Adjunct to Minimally Invasive Non-surgical Treatment of Intrabony Defects.
NCT03622255 ·Status: COMPLETED ·Phase: NA
-
Regenerative Endodontic Procedure of Immature Permanent Teeth With Apical Periodontitis Using PRF
NCT02801552 ·Status: COMPLETED ·Phase: NA
-
Conventional or Minimally Invasive Surgical Technique for the Treatment of Furcation Defects Using Enamel Matrix Derivative and Anorganic Bovine Bone - a Randomized Controlled Clinical Trial.
NCT02102360 ·Status: COMPLETED ·Phase: PHASE4
-
Minimally Invasive Flap With Platelet Rich Fibrin or Growth Factor Enhanced Matrix in Treatment of Intrabony Defect
NCT04786327 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel (MCAT)
NCT06504329 ·Status: COMPLETED ·Phase: NA